MktsMarkets

Corbus Pharmaceuticals Holdings, Inc.
NASDAQ: CRBPKey statistics
CRBP News
Stories mentioning CRBP from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 19,819 | 18,406 | 20,860 | 15,187 | 15,642 | 8,787 | 10,808 | 6,865 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 24,304 | 21,966 | 24,417 | 19,152 | 19,775 | 12,605 | 15,505 | 10,988 |
| Operating Income (Loss) | (24,304) | (21,966) | (24,417) | (19,152) | (19,775) | (12,605) | (15,505) | (10,988) |
| Interest Income | ||||||||
| Interest Expense | 652.00 | |||||||
| Other Expense | (67.00) | 1.00 | (50.00) | 176.00 | 1,116 | 1,295 | 200.00 | 43.00 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (22,969) | (20,555) | (23,342) | (17,662) | (16,978) | (9,530) | (13,783) | (9,997) |
| Earnings Per Share (Basic) | (1.23) | (1.54) | (1.90) | (1.44) | (1.39) | (0.87) | (1.15) | (0.90) |
| Earnings Per Share (Diluted) | (1.23) | (1.54) | (1.90) | (1.44) | (1.39) | (0.87) | (1.15) | (0.90) |
| Weighted Average Shares Outstanding (Basic) | 18,707 | 13,317 | 12,307 | 12,240 | 12,202 | 10,915 | 12,015 | 11,053 |
| Weighted Average Shares Outstanding (Diluted) | 18,707 | 13,317 | 12,307 | 12,240 | 12,202 | 10,915 | 12,015 | 11,053 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CRBP
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) is a stock listed on the Nasdaq Stock Market under the ticker symbol CRBP. It last traded at $3.38 (Nov 16, 2026, 4:00 PM ET), down 0.4% on the day. That gives Corbus Pharmaceuticals a market capitalisation of $64.2M.
Over the past 52 weeks CRBP has traded between $2.81 and $12.88.
For the quarter ended Mar 31, 2026 it reported a net loss of $23.0M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$23.0M |
| Dec 31, 2025 | — | -$20.6M |
| Sep 30, 2025 | — | -$23.3M |
| Jun 30, 2025 | — | -$17.7M |
From Corbus Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…